论文部分内容阅读
OBJECTIVE: To observe the effect of alprostadil combined with Shenkang injection on the treatment of chronic kidney disease of elderly patients.METHODS: We divided 86 elderly patients with chronic kidney disease into three groups.The control group was treated with routine therapy.The combined treatment group was treated with alprostadil injection and Shenkang injection, while Shenkang treatment group with Shenkang injection alone.The change of renal function (Scr, BUN, Ccr, albuminuria in 24 h, β-MG, CysC) was detected after the treatment.